2型糖尿病患者における尿酸と高密度脂質コレステロールの比率と大動脈動脈硬化症との関連に関する横断的研究
Cuihua Huang1, Yan Luo2, Jianqing Huang1
1Longyan First Affiliated Hospital of Fujian Medical University, Longyan, Fujian, 364000, People's Republic of China.
Diabetes, metabolic syndrome and obesity : targets and therapy
|August 21, 2025
まとめ
尿酸と高密度脂質タンパク質の血清コレステロール比 (UHR) は,2型糖尿病患者の頸動脈動脈硬化症 (CAS) の独立した危険因子である. UHRは,従来の心血管リスクバイオマーカーと比較して,CASの優れた予測値を示した.
科学分野:
- 内分泌学
- 心血管医学
- メタボリックシンドローム
背景:
- 動脈動脈硬化症 (CAS) は2型糖尿病の重大な合併症である.
- CASの予測バイオマーカーは,糖尿病患者の管理に不可欠です.
- 尿酸と高密度脂質タンパク質のコレステロール比 (UHR) は代謝機能障害と関連しており,バイオマーカーとして機能する.
研究 の 目的:
- 2型糖尿病患者におけるUHRとCASの関連性を調査する.
- CASに対するUHRの独立予測値を評価する.
- UHRの予測性能と従来の心血管リスク要因を比較する.
主な方法:
- 2型糖尿病患者615人を対象とした横断研究.
- 収集されたデータには人口統計,生化学マーカー,頸動脈超音波が含まれています.
- 統計的分析には,スピアーマン相関,多変数ロジスティック回帰,およびROC分析が含まれていた.
主要な成果:
- CASの患者はUHRと心血管リスクマーカーが著しく高かった.
- UHRは,大動脈内膜の厚さとCASとの投与反応関連を示した.
- UHRは独立してCASを予測し,ROC分析で他のバイオマーカーを上回った (AUC=0. 656).
結論:
- UHRは2型糖尿病におけるCASの独立した危険因子です.
- UHRは,従来のバイオマーカーと比較して,CASの優れた予測能力を示しています.
- UHRは糖尿病患者の心血管リスク評価を改善する可能性があります.
関連する概念動画
01:36Carbohydrate Metabolism
11.7K
Carbohydrates are polymers composed of molecules containing atoms of carbon, hydrogen and oxygen. One gram of carbohydrate can provide four kilo-calories of energy, which makes it the most efficient instant energy source.
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in...
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in...
11.7K
01:22Diabetes Mellitus: Type 2 and Gestational
2.9K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
2.9K
01:30Coronary Artery Disease I: Introduction
55
Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
55
01:26Atherosclerosis III: Management
33
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
33
01:26Coronary Artery Disease II: Pathophysiology
34
Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
34
01:15Diabetes: Symptoms, Diagnosis, and Complications
687
For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
687